Secure your CRISPR pipeline with scalable cGMP guide RNA
April 8, 2025 – 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT
Join us for an exclusive webinar on GenScript's cGMP Guide RNA manufacturing services, and discover how they can help accelerate your CRISPR-based therapeutic development. As a trusted partner in cell and gene therapy, GenScript provides high-quality, scalable, and regulatory-compliant synthetic guide RNA (gRNA) for a variety of CRISPR systems, including Cas9, Cas12a, prime editing, and base editing.
Dr. Pedro Teh, Senior Global Product Manager of GenScript's gene editing solutions, will explore the company's cGMP synthesis capabilities and state-of-the-art production facility, which features multiple dedicated production lines and a streamlined 30-day turnaround for clinical-grade gRNA.
Learn how GenScript's comprehensive documentation support, including Drug Master Files (DMFs), can facilitate smooth IND submissions and regulatory approvals. Whether you're in early-stage research or preparing for clinical trials, this webinar will show you how GenScript's expertise in cGMP nucleic acid manufacturing, quality control, and regulatory support can help de-risk your CRISPR therapeutic pipeline.
Key learning objectives:
- Learn about GenScript’s cGMP guide RNA manufacturing capabilities and quality control processes.
- Explore the range of gene editing approaches that GenScript can support with cGMP gRNA services
- Understand how GenScript’s documentation support simplifies IND submissions and regulatory approvals
- Learn why procuring RUO to cGMP GRNA from a single vendor streamlines and de-risks the development process for CRISPR therapies
Who should attend?
Scientists and decision-makers from biopharma, biotech, and academic institutions using gene editing for discovery or preclinical research.
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Speakers
Dr. Pedro (Jing Tsong) Teh is a Senior Global Product Manager of gene editing solutions at GenScript. He earned his Ph.D. in Molecular Biology from Ludwig Maximilian University of Munich (LMU). Dr. Teh has over 10 years’ experience in cancer and stem cell research and technical support, with previous roles at DUKE-NUS and BGI Research. His current role at GenScript focuses on marketing and business strategy planning for its end-to-end gene editing services.
Moderator
